The vast majority of genomic data used to develop precision healthcare doesn’t represent global genetic diversity
Our vision is to bring the benefits of precision healthcare to everyone, no matter where they live or where they come from.
We founded Global Gene Corp to address what we believe is the most important challenge to delivering effective precision healthcare to a global market: the lack of diversity in the genomic datasets used to inform the development of novel diagnostics and therapies.
Genetic makeup affects all aspects of health – from the risk of disease to how quickly the body breaks down drugs – and this information is increasingly being used as the basis for new tests and treatments.
Yet the vast majority of genomic data comes solely from people with white European ancestry, with 60% of the world’s population represented by less than 5% of current datasets. This means that most of the world’s population could be missing out on vital healthcare innovations based on genetic information.
We’re working with organisations around the world to collect and analyse diverse genomic and medical datasets, using patent-pending algorithms to provide unique insights and technology platforms for healthcare providers, pharmaceutical companies and more.
The human genome is a global genome. Find out more about our vision and work on our blog and follow us on Twitter.